Published in J Appl Physiol (1985) on December 12, 2008
Electrical Stimulation of Human Myocytes in Microgravity (microG) | NCT03665051
Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics (2009) 1.62
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab (2014) 1.55
Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. J Histochem Cytochem (2012) 1.51
Microgravity Reduces the Differentiation and Regenerative Potential of Embryonic Stem Cells. Stem Cells Dev (2015) 1.44
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch (2011) 1.41
Effects of a Closed Space Environment on Gene Expression in Hair Follicles of Astronauts in the International Space Station. PLoS One (2016) 1.40
Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax (2011) 1.35
MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. J Physiol (2010) 1.33
Adaptation of mouse skeletal muscle to long-term microgravity in the MDS mission. PLoS One (2012) 1.23
Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol (2010) 1.21
Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J Nutr (2009) 1.20
Spaceflight transcriptomes: unique responses to a novel environment. Astrobiology (2012) 1.12
Regulation of muscle protein synthesis and the effects of catabolic states. Int J Biochem Cell Biol (2013) 1.10
Skeletal muscle wasting with disuse atrophy is multi-dimensional: the response and interaction of myonuclei, satellite cells and signaling pathways. Front Physiol (2014) 1.08
Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone (2010) 1.06
Role of subchondral bone during early-stage experimental TMJ osteoarthritis. J Dent Res (2011) 1.04
MicroRNA in myogenesis and muscle atrophy. Curr Opin Clin Nutr Metab Care (2013) 1.04
Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting. Am J Physiol Heart Circ Physiol (2011) 1.03
MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease. Front Physiol (2013) 1.00
TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction. Front Immunol (2014) 1.00
Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin-like growth factor-1 signaling molecule. Am J Pathol (2010) 0.98
Satellite cells in human skeletal muscle plasticity. Front Physiol (2015) 0.96
CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am J Physiol Regul Integr Comp Physiol (2010) 0.96
MicroRNAs in skeletal muscle biology and exercise adaptation. Free Radic Biol Med (2013) 0.94
Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng Part A (2011) 0.92
Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis. Dev Dyn (2010) 0.91
Effects of 14 days of microgravity on fast hindlimb and diaphragm muscles of the rat. Eur J Appl Physiol (2009) 0.90
Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy. Physiol Genomics (2011) 0.90
Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction. J Appl Physiol (1985) (2013) 0.88
Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease. PLoS One (2014) 0.88
Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during bed rest and active recovery. Muscle Nerve (2010) 0.86
Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy. Front Physiol (2015) 0.85
MicroRNA-206: a promising theranostic marker. Theranostics (2014) 0.85
Various jobs of proteolytic enzymes in skeletal muscle during unloading: facts and speculations. J Biomed Biotechnol (2012) 0.85
Identification of a conserved set of upregulated genes in mouse skeletal muscle hypertrophy and regrowth. J Appl Physiol (1985) (2014) 0.84
The role of microRNAs in skeletal muscle health and disease. Front Biosci (Landmark Ed) (2015) 0.84
Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy. Am J Physiol Regul Integr Comp Physiol (2010) 0.84
Acute molecular response of mouse hindlimb muscles to chronic stimulation. Am J Physiol Cell Physiol (2009) 0.83
Stem cell health and tissue regeneration in microgravity. Stem Cells Dev (2014) 0.81
Gene Expression Profiling in Slow-Type Calf Soleus Muscle of 30 Days Space-Flown Mice. PLoS One (2017) 0.80
Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes. J Biol Chem (2015) 0.80
Frontier impact of microRNAs in skeletal muscle research: a future perspective. Front Physiol (2015) 0.80
Effects of simulated microgravity on embryonic stem cells. PLoS One (2011) 0.80
PlanHab (Planetary Habitat Simulation): the combined and separate effects of 21 days bed rest and hypoxic confinement on human skeletal muscle miRNA expression. Physiol Rep (2016) 0.78
Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity. PLoS One (2013) 0.78
Masticatory muscles of mouse do not undergo atrophy in space. FASEB J (2015) 0.78
The stress protein/chaperone Grp94 counteracts muscle disuse atrophy by stabilizing subsarcolemmal neuronal nitric oxide synthase. Antioxid Redox Signal (2013) 0.78
Neural stem/progenitor cell properties of glial cells in the adult mouse auditory nerve. Sci Rep (2015) 0.77
Spaceflight alters the gene expression profile of cervical cancer cells. Chin J Cancer (2011) 0.77
Microgravity-Induced Transcriptome Adaptation in Mouse Paraspinal longissimus dorsi Muscle Highlights Insulin Resistance-Linked Genes. Front Physiol (2017) 0.77
Transition from physical activity to inactivity increases skeletal muscle miR-148b content and triggers insulin resistance. Physiol Rep (2016) 0.76
Simulated Microgravity Exerts an Age-Dependent Effect on the Differentiation of Cardiovascular Progenitors Isolated from the Human Heart. PLoS One (2015) 0.76
C/EBPα represses slow myosin heavy chain 2 gene expression in developing avian myotubes. Biochim Biophys Acta (2016) 0.75
The Signature of MicroRNA Dysregulation in Muscle Paralyzed by Spinal Cord Injury Includes Downregulation of MicroRNAs that Target Myostatin Signaling. PLoS One (2016) 0.75
miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy. Neural Regen Res (2016) 0.75
Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing? Pharm Res (2016) 0.75
Changes in apoptotic microRNA and mRNA expression profiling in Caenorhabditis elegans during the Shenzhou-8 mission. J Radiat Res (2015) 0.75
Molecular characterization of myostatin from the skeletal muscle of the African lungfish, Protopterus annectens, and changes in its mRNA and protein expression levels during three phases of aestivation. J Comp Physiol B (2017) 0.75
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol (2001) 15.02
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol (2003) 3.41
1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A (1994) 3.37
Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res (2008) 3.18
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem (2002) 3.07
MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol (2006) 2.85
MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Physiol (1985) (2006) 2.63
Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol (2006) 2.13
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab (2001) 1.84
Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem (2002) 1.72
Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol (1999) 1.68
Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol (2006) 1.66
Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol (2006) 1.63
Muscling through the microRNA world. Exp Biol Med (Maywood) (2008) 1.55
Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol (2002) 1.44
Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity. Physiol Genomics (2003) 1.41
The PowerAtlas: a power and sample size atlas for microarray experimental design and research. BMC Bioinformatics (2006) 1.36
The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol (2007) 1.23
Skeletal muscle gene expression in space-flown rats. FASEB J (2004) 1.18
Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med (2007) 1.13
ArrayQuest: a web resource for the analysis of DNA microarray data. BMC Bioinformatics (2005) 1.13
Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol (2000) 1.07
C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle. Am J Physiol Regul Integr Comp Physiol (2002) 1.05
Transcriptional reprogramming and ultrastructure during atrophy and recovery of mouse soleus muscle. Physiol Genomics (2004) 1.04
Skeletal muscle adaptations to microgravity exposure in the mouse. J Appl Physiol (1985) (2003) 1.03
Prolonged unloading of rat soleus muscle causes distinct adaptations of the gene profile. FASEB J (2002) 1.02
Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. I. Immune population distributions. J Appl Physiol (1985) (2003) 1.02
Regulation of mTOR by mechanically induced signaling events in skeletal muscle. Cell Cycle (2006) 1.01
The MUSC DNA Microarray Database. Bioinformatics (2003) 0.94
Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets. J Appl Physiol (1985) (2002) 0.93
Energy metabolism pathways in rat muscle under conditions of simulated microgravity. J Nutr Biochem (2002) 0.92
Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscle. Toxicol Sci (2006) 0.90
Alteration of gene expression profiles in skeletal muscle of rats exposed to microgravity during a spaceflight. J Gravit Physiol (2002) 0.87
Animals and spaceflight: from survival to understanding. J Musculoskelet Neuronal Interact (2007) 0.85
Spaceflight effects on single skeletal muscle fiber function in the rhesus monkey. Am J Physiol Regul Integr Comp Physiol (2000) 0.84
Response of the neuromuscular unit to spaceflight: what has been learned from the rat model. Exerc Sport Sci Rev (1996) 0.82
Weightlessness simulations for cardiovascular and muscle systems: validity of rat models. J Gravit Physiol (1997) 0.81
Contribution of dietary and loading changes to the effects of suspension on mouse femora. J Exp Zool (1994) 0.80
Osteoclast differentiation and activation. Nature (2003) 18.59
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell (2010) 5.23
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res (2008) 4.82
Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol (2004) 4.49
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res (2009) 4.40
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest (2003) 3.09
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone (2006) 2.59
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res (2010) 2.52
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. J Bone Miner Res (2009) 2.51
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation (2008) 2.44
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell (2009) 2.20
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol (1985) (2002) 2.15
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension (2002) 2.11
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov (2012) 2.07
Bone development and age-related bone loss in male C57BL/6J mice. Bone (2003) 2.02
Diverse roles for the LDL receptor family. Trends Endocrinol Metab (2002) 1.99
VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood (2004) 1.81
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. Endocrinology (2005) 1.78
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res (2011) 1.70
Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res (2009) 1.68
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats. J Bone Miner Res (2010) 1.65
Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood (2002) 1.58
Microarray analysis of spaceflown murine thymus tissue reveals changes in gene expression regulating stress and glucocorticoid receptors. J Cell Biochem (2010) 1.57
Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol (2003) 1.56
Megalin functions as an endocytic sonic hedgehog receptor. J Biol Chem (2002) 1.49
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis (2007) 1.42
Diamagnetic levitation changes growth, cell cycle, and gene expression of Saccharomyces cerevisiae. Biotechnol Bioeng (2007) 1.37
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res (2007) 1.36
Evidence that the satin hair mutant gene Foxq1 is among multiple and functionally diverse regulatory targets for Hoxc13 during hair follicle differentiation. J Biol Chem (2006) 1.34
Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30
Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem (2005) 1.28
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum (2009) 1.27
Early increase in osteoclast number in mice after whole-body irradiation with 2 Gy X rays. Radiat Res (2008) 1.26
Fibulin-1 is required for morphogenesis of neural crest-derived structures. Dev Biol (2008) 1.26
Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol (2002) 1.25
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.24
Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn (2007) 1.24
High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem (2008) 1.23
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn (2006) 1.22
Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet (2011) 1.20
Effects of spaceflight on innate immune function and antioxidant gene expression. J Appl Physiol (1985) (2009) 1.20
Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations. Bone (2009) 1.20
Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development. Matrix Biol (2003) 1.20
Spaceflight effects on T lymphocyte distribution, function and gene expression. J Appl Physiol (1985) (2008) 1.16
Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol (2007) 1.15
ArrayQuest: a web resource for the analysis of DNA microarray data. BMC Bioinformatics (2005) 1.13
Megalin binds and internalizes angiotensin II. Am J Physiol Renal Physiol (2004) 1.13
Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol (2010) 1.11
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J Bone Miner Res (2005) 1.11
Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL. J Biol Chem (2010) 1.10
Long-term dose response of trabecular bone in mice to proton radiation. Radiat Res (2008) 1.08
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol (2007) 1.08
Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther (2012) 1.06
RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res (2008) 1.06
Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation. BMC Dev Biol (2006) 1.06
Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem (2004) 1.05
Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone. J Bone Miner Res (2007) 1.05
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. J Bone Miner Res (2011) 1.05
Megalin binds and internalizes angiotensin-(1-7). Am J Physiol Renal Physiol (2005) 1.04
Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2013) 1.04
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells. Atherosclerosis (2008) 1.04
Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci (2003) 1.04
Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int (2008) 1.03
Megalin and the neurodevelopmental biology of sonic hedgehog and retinol. J Cell Sci (2003) 1.03
Light chains are a ligand for megalin. J Appl Physiol (1985) (2004) 1.02
Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. I. Immune population distributions. J Appl Physiol (1985) (2003) 1.02
Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res (2007) 1.02
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis (2011) 1.01
Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats. Endocrinology (2011) 1.00
Effect of proton irradiation followed by hindlimb unloading on bone in mature mice: a model of long-duration spaceflight. Bone (2012) 1.00
New variants in the Enpp1 and Ptpn6 genes cause low BMD, crystal-related arthropathy, and vascular calcification. J Bone Miner Res (2009) 0.99
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res (2003) 0.99
One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. J Bone Miner Res (2009) 0.99